Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes have priced
Quarterly results
Clovis Oncology, Inc. (CLVS) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/11/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
07/11/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
07/11/2023 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Changes in Control of Registrant, Departure...
Docs: "Findings of Fact, Conclusions of Law, and Order (I) Approving Disclosure Statement on a Final Basis and (II) Confirming the Third Amended Joint Chapter 11 Plan of Liquidation of Clovis Oncology, Inc. and Its Affiliated Debtors Pursuant to Chapter 11 of the Bankruptcy Code",
"Findings of Fact, Conclusions of Law, and Order (I) Approving Disclosure Statement on a Final Basis and (II) Confirming the Third Amended Joint Chapter 11 Plan of Liquidation of Clovis Oncology, Inc. and Its Affiliated Debtors Pursuant to Chapter 11 of the Bankruptcy Code"
06/30/2023 8-K Material Modifications to Rights of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Clovis Oncology, Inc., Monthly Operating Report",
"Clovis Oncology Ireland Limited, Monthly Operating Report",
"Clovis Oncology UK Limited, Monthly Operating Report"
06/02/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Clovis Oncology, Inc., Monthly Operating Report",
"Clovis Oncology Ireland Limited, Monthly Operating Report",
"Clovis Oncology UK Limited, Monthly Operating Report"
05/03/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Clovis Oncology, Inc., Monthly Operating Report",
"Clovis Oncology Ireland Limited, Monthly Operating Report",
"Clovis Oncology UK Limited, Monthly Operating Report"
05/01/2023 8-K Completion of Acquisition or Disposition of Assets  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
04/14/2023 8-K Quarterly results
04/06/2023 8-K Acquisition/merger/asset purchase announced
Docs: "Asset Purchase Agreement, by and between Clovis Oncology, Inc. and pharma& Schweiz GmbH",
"Asset Purchase Agreement, by and between Clovis Oncology, Inc. and pharma& Schweiz GmbH"
03/31/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Clovis Oncology, Inc., Monthly Operating Report",
"Clovis Oncology Ireland Limited, Monthly Operating Report",
"Clovis Oncology UK Limited, Monthly Operating Report"
03/02/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Clovis Oncology, Inc., Monthly Operating Report",
"Clovis Oncology Ireland Limited, Monthly Operating Report",
"Clovis Oncology UK Limited, Monthly Operating Report"
02/10/2023 SC 13G/A HIGHBRIDGE CAPITAL MANAGEMENT LLC reports a 3.9% stake in Clovis Oncology, Inc.
12/29/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/19/2022 8-K Quarterly results
12/13/2022 8-K Quarterly results
12/13/2022 8-K Quarterly results
12/02/2022 8-K Quarterly results
11/16/2022 8-K Quarterly results
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy